AstraZeneca became the latest biotechnology company to expand its manufacturing operations in Maryland when the British drugmaker announced plans last month to enlarge a production facility and add 300 workers in Frederick.
AstraZeneca became the latest biotechnology company to expand its manufacturing operations in Maryland when the British drugmaker announced plans last month to enlarge a production facility and add 300 workers in Frederick.